---
title: Ketamine and neuroplasticity
videoId: Rxmv7rT9leo
---

From: [[hubermanlab]] <br/> 
Ketamine, a compound originally known for its anesthetic properties, has gained attention in recent years for its potential to treat depression, suicidality, and PTSD. Its effects on the brain and its ability to induce [[neuroplasticity_and_the_potential_for_behavioral_change | neuroplasticity]], however, are intriguing aspects that warrant a closer look.

## Understanding Neuroplasticity

Neuroplasticity refers to the ability of the nervous system to change in response to experience. This is a fundamental process for learning and memory, involving the strengthening and formation of new neural connections. At the molecular level, neuroplasticity involves factors like Brain-Derived Neurotrophic Factor (BDNF), which is crucial for [[optimal_strategies_for_studying_and_learning | learning and memory]] [00:01:55](<a class="yt-timestamp" data-t="00:01:55">[00:01:55]</a>).

## Ketamine's Mechanism of Action

Ketamine works primarily by acting as an NMDA receptor antagonist. NMDA receptors are known to be critical for neuroplasticity because they serve as "and gates" — requiring both glutamate binding and significant electrical activity to activate. This activation leads to the recruitment of other neurotransmitter receptors and structural changes in neurons, facilitating long-term potentiation, a foundation of neuroplastic change [00:35:54](<a class="yt-timestamp" data-t="00:35:54">[00:35:54]</a>).

However, ketamine's role as an NMDA receptor blocker seems paradoxical because it appears to both inhibit normal NMDA receptor functions and yet promotes neuroplasticity. This is primarily because ketamine affects inhibitory neurons by blocking NMDA receptors more actively on these neurons, reducing their inhibitory activity on excitatory circuits. This leads to increased excitatory neuron "bursting," which is an activity pattern conducive to inducing [[understanding_dopamines_role_in_motivation_and_satisfaction | neuroplasticity]] [00:46:46](<a class="yt-timestamp" data-t="00:46:46">[00:46:46]</a>).

## The Role of BDNF

BDNF release is another mechanism by which ketamine induces neuroplasticity. Bursting activity of excitatory neurons can stimulate the release of BDNF, which enhances the plasticity and remodeling of neural circuits. What’s fascinating is that ketamine itself may directly trigger the release of BDNF, or mimic its actions by binding to similar receptors, thus promoting [[biological_basis_of_depression_and_mood_disorders | neuroplasticity]] in mood-related circuits [00:56:04](<a class="yt-timestamp" data-t="00:56:04">[00:56:04]</a>).

## Implications for Depression Treatment

In clinical settings, ketamine provides rapid antidepressant effects, often in conjunction with traditional therapies, offering relief where other treatments might fail. The drug's dual pathway — immediate relief through dissociation and longer-term relief through neural remodeling — is crucial for understanding its therapeutic potential. These mechanisms suggest that ketamine doesn’t just temporarily alleviate symptoms but may help rewire emotional and cognitive pathways towards [[the_power_of_play_in_brain_development_and_neuroplasticity | healthier patterns]] [01:03:33](<a class="yt-timestamp" data-t="01:03:33">[01:03:33]</a>).

## Conclusion

The insights into ketamine's interaction with the brain shed light on its potential not only as a fast-acting antidepressant but also as a tool for inducing beneficial neuroplastic changes. While more research is necessary to explore the long-term outcomes and potential side effects of its use, particularly outside clinical contexts, ketamine's role in advancing our understanding of neuroplasticity cannot be understated. The compound represents a promising [[experimental_treatments_for_depression | frontier in the treatment of depression]] and possibly other disorders characterized by deficits in neuroplasticity [01:14:11](<a class="yt-timestamp" data-t="01:14:11">[01:14:11]</a>).